Editorial: how safe is it to administer the BCG vaccination to babies exposed to anti-TNFα medications antenatally? Authors' reply
Aliment Pharmacol Ther
.
2019 Dec;50(11-12):1240-1241.
doi: 10.1111/apt.15559.
Authors
Maxime Luu
1
2
,
Eric Benzenine
3
,
Alan Barkun
4
,
Muriel Doret
5
,
Christophe Michiels
6
,
Thibault Degand
6
,
Catherine Quantin
3
7
,
Marc Bardou
1
2
Affiliations
1
Plurithematic Unit, INSERM, CIC1432, Dijon, France.
2
Plurithematic Unit, Clinical Investigation Center, Dijon-Bourgogne University Hospital, Dijon, France.
3
Biostatistics and Bioinformatics Department, Dijon Bourgogne University Hospital, Dijon, France.
4
The McGill University Health Centre, Montreal General Hospital, McGill University, Montreal, Canada.
5
Service de Gynécologie Obstétrique, Hospices Civils de Lyon, Hôpital Femme-Mère-Enfant, Bron, France.
6
Division of Gastroenterology, Dijon Bourgogne University Hospital, Dijon, France.
7
INSERM, Biostatistics, Biomathematics, Pharmacoepidemiology and Infectious Diseases (B2PHI), UVSQ, Institut Pasteur, Université Paris-Saclay, Paris, France.
PMID:
31709611
DOI:
10.1111/apt.15559
No abstract available
Publication types
Editorial
Comment
MeSH terms
BCG Vaccine
Colonic Pouches*
Humans
Infant
Pouchitis*
Vaccination
Substances
BCG Vaccine